Tagged: leadership commitment to DEI

The future of pharma shines through a compelling story about clinical trial transformation. FDA-approved trial participants were 84% white in 2014, but this number dropped by a lot to 50% by 2023. This change shows our industry’s new approach to diversity. The pharmaceutical industry now experiences unprecedented...